The Venture Codex Logo

The Venture Codex

Overview

Invests in and supports healthcare innovation and product development.

Founded

2012

Deals ยท 12mo

1

Stage focus

Series B

Geographic focus

United States

Sector focus

Health Care

Investment portfolio

20rounds
NAMEDATESIZE
410 Medical
Jul 2026Participated
$12 MOther Equity
Reprieve Cardiovascular
Aug 2025Participated
$61 MSeries B
Carta Healthcare
May 2025Participated
$18 MSeries B
Arrivo BioVentures LLC
Nov 2023Participated
$45 MSeries B
Arrivo
Nov 2023Participated
$45 MSeries B
Censinet
Jan 2023Participated
$9 MOther Equity
Vergent Bioscience
Oct 2022Participated
$22 MSeries B
Rediscovery Life Sciences
Sep 2020Led
$5 MSeries B
Bardy Diagnostics
Apr 2019Participated
$36 MSeries B
Phynd Technologies
Jan 2019Participated
$8 MSeries B
Gauss Surgical
Oct 2018Participated
$20 MSeries C
Emergo Therapeutics
May 2018Led
$12 MSeries A
410 Medical
Jul 2026Participated
$12 MOther Equity
Reprieve Cardiovascular
Aug 2025Participated
$61 MSeries B
Carta Healthcare
May 2025Participated
$18 MSeries B
Arrivo BioVentures LLC
Nov 2023Participated
$45 MSeries B
Arrivo
Nov 2023Participated
$45 MSeries B
Censinet
Jan 2023Participated
$9 MOther Equity
Vergent Bioscience
Oct 2022Participated
$22 MSeries B
Rediscovery Life Sciences
Sep 2020Led
$5 MSeries B
Bardy Diagnostics
Apr 2019Participated
$36 MSeries B
Phynd Technologies
Jan 2019Participated
$8 MSeries B
Gauss Surgical
Oct 2018Participated
$20 MSeries C
Emergo Therapeutics
May 2018Led
$12 MSeries A
20
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Rex Health Ventures: 20 funding rounds are recorded in the selected participation categories.All available history.
Rex Health Ventures: 20 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B18
Series C+03
Other Equity16

Monthly Deal Activity

Rex Health Ventures: 20 deals are recorded across 172 months.All available history.
Rex Health Ventures: 20 deals are recorded across 172 months. All available history
MonthDeals
Jul '121
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '141
Jan '151
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '151
Aug '150
Sep '151
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '161
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '161
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '181
Jun '180
Jul '180
Aug '180
Sep '180
Oct '181
Nov '180
Dec '180
Jan '191
Feb '190
Mar '190
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '232
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '251
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

Rex Health Ventures: Health & Life Sciences is the largest displayed sector by deal count (17 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Rex Health Ventures: Health & Life Sciences is the largest displayed sector by deal count (17 deals). All available history
SectorDeals
Health & Life Sciences17
Enterprise Software4
Space & Frontier Tech3
Hardware & Robotics2
Manufacturing2
Professional Services2
Travel & Hospitality1
Networks, Cloud & Communication1
Cybersecurity & Privacy1
AI & Machine Learning1
Food & Agriculture1
Data, Analytics & IT1
Transportation & Logistics1

Deal Size Distribution

Rex Health Ventures: 20 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Rex Health Ventures: 20 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M8
$25M-$50M6
$50M-$100M2
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Rex Health Ventures: United States has the largest recorded deal count among the displayed regions (20 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Rex Health Ventures: United States has the largest recorded deal count among the displayed regions (20 deals). All available history
RegionDeals
United States20
Rex Health Ventures: 20 co-investors are shown, with Orlando Health Ventures sharing 6 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Rex Health Ventures: Led accounts for 15% and participating for 85% of round participation.All available history.
Rex Health Ventures: Led accounts for 15% and participating for 85% of round participation. All available history
CategoryDeals (count)Share (%)
Led315%
Participating1785%
Rex Health Ventures: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
Rex Health Ventures: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead267%
Co-led133%

Team

Anita Watkins

Managing Director

Ray Jang

Senior Associate